Administrative and Public LawBanking and Financial Markets LitigationCivil Fraud, Asset Tracing and RecoveryCommercial LitigationCompetition LawConstruction and Engineering DisputesContentious Trusts, Estates and Private Wealth DisputesGroup Action LitigationInsolvency LitigationInsurance and Reinsurance LitigationInternational ArbitrationInvestigations and White Collar CrimeProduct LiabilityProfessional Negligence LitigationToxic Tort and ESG
Founded in 2012, Signature Litigation has grown into one of London’s pre-eminent specialist dispute resolution practices. From the outset, we set out to do things differently: a conflict-free, disputes-only platform designed to give clients the undivided focus and strategic agility that complex, high-stakes matters demand.
FIND OUT MORE
Established in 2017, Signature Litigation's Gibraltar office was founded to address growing demand for specialist expertise in commercial litigation and private wealth disputes on the Rock.
FIND OUT MORE
Signature Litigation AARPI houses one of France’s most enviable product liability practices, with the team also handling commercial and corporate litigation, insurance and reinsurance, toxic tort and ESG, civil fraud and asset tracing, international arbitration, administrative and public law.
FIND OUT MORE
Frankfurt has emerged as one of Europe's foremost financial and commercial centres and, increasingly, as a bridge between European and Asian markets. With that growth comes an increasing demand for sophisticated dispute resolution. Signature Litigation established its Frankfurt office to meet this need, bringing our conflict-free, disputes-only platform to the German market.
FIND OUT MOREPartners Sylvie Gallage-Alwis and Thomas Rouhette have authored the France jurisdiction chapter in the newly published Medical Devices & Consumer Health Products 2021 Global Practice Guide. They have also authored the 2021 trends and developments section of their chapter. In their chapter, Sylvie and Thomas discuss applicable product safety regulatory regimes, commercialisation and product life cycles, regulator engagement and enforcement, liability, and policy and legislative reform. They also examine recent trends and developments in the health and medical devices industry, such as the regulation of pharmaceutical sales, anti-gift regulation, medical device innovation, AI in healthcare technology, and PIP implant litigation.
The Medical Devices & Consumer Health Products 2021 guide covers 16 jurisdictions and provides the latest legal information on product safety regulatory regimes; corporate social responsibility (CSR), the environment and sustainability; advertising and product claims; marketing and sales; regulator engagement and enforcement; liability; and the impact of Brexit and COVID-19.
A link to Sylvie and Thomas' contributions can be found here, and a link to the full Guide can be found here.
